Source | Message
(content) | Channel
(process) | Receiver
(audience) | Outcome | Eval-
uation |
NIH/
NCI | Improving detection of melanoma | Audiovisuals, videotapes, pamphlets, slides | General public, health professionals, patients, clinicians | Reduced incidence rates, cost savings in surgery and hospitalisation. | Impact |
NIH/
NLM | Rapid dissemin-
ation and access to vital health information | MEDLARS network | Health professionals, librarians | Praise, concern and disappointment from health care community. | None |
CDC/
NCEH | Exposure to radiation doses | Printed mats., 800 #, media outreach, public mtgs. | Community around Hanford Nuclear Facility | Build community trust and support | Process, outcome |
NIH/
NIEHS | Fluoride's overall risks and benefits | Professional journals, public communication | Communities, public advocacy groups | Allay public concerns, prevent cessation of fluoridation programmes | Informal |
FDA | Notify and alert TMJ patients | Media outreach, press releases, journal advertise- ments, notification letters | Patients, health professionals | Patients motivated to action (I.e.: joined registry, contacted physician | Under-
way |
NIH/
NIMH | Reducing risky sexual behaviours | Videotapes, skills training, private counseling | Teenage runaways | Increase in condom use,reduce high- risk behaviour patterns. | Process, impact |
ATSDR | Environ-
mental education and information for health profess-
ionals | Case Studies in Environmental Medicine series | Health care professionals | Enhance communication betw. physician and patient, improve diagnostic and treatment skills. | Process |
FDA | Identify and alert heart valve patients | Press releases, press confs., notification letters, journal ads. | Patients, consumers, health profs., manufacturers. | Identified and notified 16,000 of 23,000 patients | Process |
NIH/
NIEHS | Chronic drug users are at risk for developing kidney disease. | Press releases, background material, news- paper articles. | Consumers, physicians, manufacturers | Create awareness about risk of analgesic use | Un-
specified |
ATSDR | Explain science, build trust and credibility | Public sessions, community org.s, interpersonal contact, media outreach | Community, environmental activists, other fed. agencies | Increase public trust and support | Process |
